Skip to main content

Advertisement

Peer Review reports

From: Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer

Original Submission
3 Feb 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 Sep 2015 Editorially accepted
1 Oct 2015 Article published 10.1186/s12916-015-0493-2

You can find further information about peer review here.

Back to article page